These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 25483535)

  • 61. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunity to hepatitis A when outbreaks of infection in men who have sex with men (MSM) are rare.
    Weerakoon AP; Chen MY; Read TR; Bradshaw C; Fairley CK
    Vaccine; 2012 May; 30(23):3430-4. PubMed ID: 22449421
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preventing hepatitis A and hepatitis B virus infections among men who have sex with men.
    Kahn J
    Clin Infect Dis; 2002 Dec; 35(11):1382-7. PubMed ID: 12439802
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
    Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
    Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The changing epidemiology of hepatitis A in Arizona following intensive immunization programs (1988-2007).
    Erhart LM; Ernst KC
    Vaccine; 2012 Sep; 30(42):6103-10. PubMed ID: 22835739
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Hepatitis B in Poland in 2010].
    Stepień M; Czarkowski MP
    Przegl Epidemiol; 2012; 66(2):277-85. PubMed ID: 23101217
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prospects for vaccination against hepatitis A and B in Catalonia (Spain).
    Salleras L; Bruguera M; Buti M; Domíngez A
    Vaccine; 2000 Feb; 18 Suppl 1():S80-2. PubMed ID: 10683557
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost-benefit analysis of hepatitis a vaccination in Thailand.
    Teppakdee A; Tangwitoon A; Khemasuwan D; Tangdhanakanond K; Suramaethakul N; Sriratanaban J; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):118-27. PubMed ID: 12118439
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunization against hepatitis A during an outbreak in a Jewish Orthodox community--Quebec, 1997-1998.
    Deshaies D; Dion R; Valiquette L; Auger N
    Can Commun Dis Rep; 1998 Sep; 24(18):145-51. PubMed ID: 9780447
    [No Abstract]   [Full Text] [Related]  

  • 70. Widespread Hepatitis A Outbreaks Associated with Person-to-Person Transmission - United States, 2016-2020.
    Foster MA; Hofmeister MG; Yin S; Montgomery MP; Weng MK; Eckert M; Nelson NP; Mermin J; Wester C; Teshale EH; Gupta N; Cooley LA;
    MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(39):1229-1234. PubMed ID: 36173747
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hepatitis A in Poland in 2013.
    Baumann-Popczyk A
    Przegl Epidemiol; 2015; 69(2):247-50, 367-9. PubMed ID: 26233081
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The epidemiology and control of hepatitis A.
    Maguire H; Heptonstall J; Begg NT
    Commun Dis Rep CDR Rev; 1992 Sep; 2(10):R114-7. PubMed ID: 1284926
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Hepatitis A: who to immunize?].
    Gendrel D
    Presse Med; 2008 Nov; 37(11):1535-7. PubMed ID: 18834696
    [No Abstract]   [Full Text] [Related]  

  • 74. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine.
    McMahon BJ; Beller M; Williams J; Schloss M; Tanttila H; Bulkow L
    Arch Pediatr Adolesc Med; 1996 Jul; 150(7):733-9. PubMed ID: 8673200
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A dynamic model for assessing universal Hepatitis A vaccination in Canada.
    Bauch CT; Rao AS; Pham BZ; Krahn M; Gilca V; Duval B; Chen MH; Tricco AC
    Vaccine; 2007 Feb; 25(10):1719-26. PubMed ID: 17229493
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Exploration of cost effectiveness of active vaccination in the control of a school outbreak of hepatitis A in a deprived community in the United Kingdom.
    Taylor-Robinson DC; Regan M; Crowcroft N; Parry JV; Dardamissis E
    Euro Surveill; 2007 Dec; 12(12):E5-6. PubMed ID: 18076861
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Patient awareness of need for hepatitis a vaccination (prophylaxis) before international travel.
    Liu SJ; Sharapov U; Klevens M
    J Travel Med; 2015; 22(3):174-8. PubMed ID: 25619557
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effectiveness of a hepatitis A vaccination program for migrant children in Amsterdam, The Netherlands (1992-2004).
    Sonder GJ; Bovée LP; Baayen TD; Coutinho RA; van den Hoek JA
    Vaccine; 2006 Jun; 24(23):4962-8. PubMed ID: 16675076
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vaccination against hepatitis A during outbreaks starting in schools: what can we learn from experiences in central Italy?
    Bonanni P; Franzin A; Staderini C; Pitta M; Garofalo G; Cecconi R; Santini MG; Lai P; Innocenti B
    Vaccine; 2005 Mar; 23(17-18):2176-80. PubMed ID: 15755590
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Quantifying the impact of hepatitis A immunization in the United States, 1995-2001.
    Samandari T; Bell BP; Armstrong GL
    Vaccine; 2004 Oct; 22(31-32):4342-50. PubMed ID: 15474727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.